AORT
Artivion Inc

324
Loading...
Loading...
News
all
press releases
Are Options Traders Betting on a Big Move in Artivion Stock?
Investors need to pay close attention to AORT stock based on the movements in the options market lately.
Zacks·15d ago
News Placeholder
More News
News Placeholder
Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
Artivion (AORT) delivered earnings and revenue surprises of +118.18% and +4.36%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Penumbra (PEN) Surpasses Q2 Earnings and Revenue Estimates
Penumbra (PEN) delivered earnings and revenue surprises of +6.17% and +3.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results
Artivion Reports Fourth Quarter and Full Year 2024 Financial Results Artivion Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire ATLANTA, Feb. 24, 2025 Fourth Quarter Highlights...
PR Newswire·8mo ago
News Placeholder
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2024 Financial Results Artivion Announces Release Date and Teleconference Call Details for Fourth...
PR Newswire·8mo ago
News Placeholder
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting Artivion Announces Presentation of Late-Breaking Data from AMDS...
PR Newswire·9mo ago
News Placeholder
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis PR Newswire ATLANTA, Dec. 9, 2024...
PR Newswire·10mo ago
News Placeholder
Artivion Reports Third Quarter 2024 Financial Results
Artivion Reports Third Quarter 2024 Financial Results Artivion Reports Third Quarter 2024 Financial Results PR Newswire ATLANTA, Nov. 7, 2024 Third Quarter Highlights: Achieved revenue of $95.8...
PR Newswire·11mo ago
News Placeholder
Artivion to Participate in Upcoming Investor Conferences
Artivion to Participate in Upcoming Investor Conferences Artivion to Participate in Upcoming Investor Conferences PR Newswire ATLANTA, Nov. 5, 2024 ATLANTA, Nov. 5, 2024 /PRNewswire/ --Artivion, Inc...
PR Newswire·11mo ago
News Placeholder
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024...
PR Newswire·1y ago

Latest AORT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.